NasdaqGM - Delayed Quote USD

SIGA Technologies, Inc. (SIGA)

8.64 -0.02 (-0.23%)
At close: April 25 at 4:00 PM EDT
8.35 -0.29 (-3.36%)
After hours: April 25 at 7:55 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
139,917.22
139,917.22
110,775.61
133,670.45
124,959.30
Cost of Revenue
34,253.03
34,253.03
32,958.20
26,544.07
25,736.35
Gross Profit
105,664.19
105,664.19
77,817.41
107,126.38
99,222.96
Operating Expense
22,043.02
22,043.02
35,117.24
18,033.58
14,722.33
Operating Income
83,621.17
83,621.17
42,700.17
89,092.80
84,500.63
Net Non Operating Interest Income Expense
--
--
--
--
-3,016.82
Other Income Expense
4,155.51
4,155.51
1,432.57
218.94
-7,975.22
Pretax Income
87,776.67
87,776.67
44,132.73
89,311.74
73,508.59
Tax Provision
19,707.85
19,707.85
10,227.93
19,860.98
17,166.58
Net Income Common Stockholders
68,068.83
68,068.83
33,904.81
69,450.77
56,342.01
Average Dilution Earnings
--
--
-400.66
-117.77
--
Diluted NI Available to Com Stockholders
68,068.83
68,068.83
33,504.14
69,333.00
56,342.01
Basic EPS
-0.08
0.95
0.46
0.92
0.71
Diluted EPS
-0.08
0.95
0.46
0.91
0.71
Basic Average Shares
71,826.46
71,362.21
72,929.55
75,322.19
79,259.00
Diluted Average Shares
71,923.92
71,679.27
73,546.50
76,402.72
79,437.31
Total Operating Income as Reported
83,621.17
83,621.17
42,700.17
89,092.80
84,500.63
Total Expenses
56,296.06
56,296.06
68,075.44
44,577.66
40,458.67
Net Income from Continuing & Discontinued Operation
68,068.83
68,068.83
33,904.81
69,450.77
56,342.01
Normalized Income
68,068.83
68,068.83
33,597.10
69,359.14
62,858.61
Interest Expense
--
--
--
--
3,016.82
Net Interest Income
--
--
--
--
-3,016.82
EBIT
83,621.17
83,621.17
42,700.17
89,092.80
76,525.41
EBITDA
84,159.46
84,159.46
43,217.81
89,615.17
77,055.22
Reconciled Cost of Revenue
34,253.03
34,253.03
32,958.20
26,544.07
25,736.35
Reconciled Depreciation
538.29
538.29
517.64
522.37
529.81
Net Income from Continuing Operation Net Minority Interest
68,068.83
68,068.83
33,904.81
69,450.77
56,342.01
Total Unusual Items Excluding Goodwill
--
--
400.66
117.77
-8,507.31
Total Unusual Items
--
--
400.66
117.77
-8,507.31
Normalized EBITDA
84,159.46
84,159.46
42,817.15
89,497.40
85,562.53
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
--
92.95
26.14
-1,990.71
12/31/2020 - 9/10/1997

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EBS Emergent BioSolutions Inc.
1.9500
-10.55%
 
LNTH Lantheus Holdings, Inc.
65.20
-0.02%
 
AQST Aquestive Therapeutics, Inc.
3.9300
+0.77%
 
DCPH Deciphera Pharmaceuticals, Inc.
14.18
-3.01%
 
SXTC China SXT Pharmaceuticals, Inc.
1.0300
-3.74%
 
ALVO Alvotech
13.65
+0.81%
 
PTPI Petros Pharmaceuticals, Inc.
0.6399
+0.87%
 
EGRX Eagle Pharmaceuticals, Inc.
4.2400
-6.81%
 
HCM HUTCHMED (China) Limited
18.99
+3.15%
 
AMPH Amphastar Pharmaceuticals, Inc.
40.83
-0.41%